Study of ONO-7579 in Patients With Advanced Solid Tumors/ NTRK Gene Fusion Positive Advanced Solid Tumors
Clinical trial NCT03182257 · TERMINATED
Trial details
- NCT number
- NCT03182257
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-12
- Primary completion
- 2018-01-30
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.